Isolation of a novel complement regulatory factor (GCRF) from glomerular epithelial cells

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Cultured rat glomerular epithelial cells (GEC) possess the ability to inhibit both antibody-directed and spontaneous complement activation.
• The complement system plays a crucial role in innate and adaptive immunity, and its dysregulation is implicated in various diseases.

Purpose of the Study:

• To isolate and characterize a novel complement regulatory factor (GCRF) synthesized by cultured rat GEC.
• To elucidate the biochemical nature and functional properties of GCRF in complement inhibition.

Main Methods:

• Isolation of GCRF from solubilized GEC and culture supernatant using Triton X-114 extraction.
• Purification guided by the ability to accelerate the decay of alternative pathway C3/C5 convertases (EC3bBbP).
• Biochemical characterization involving chromatography (Mono Q, Superose 6) and enzymatic digestion (chondroitinase ABC, neuraminidase, trypsin, heparitinase, chondroitinase AC).

Main Results:

• GCRF was successfully isolated and purified from GEC.
• GCRF significantly accelerated the decay of EC3bBbP (reducing t1/2 from 128 to 41 minutes) and inhibited its formation in a dose-dependent manner.
• Enzymatic digestion revealed GCRF to be a sialic acid-containing dermatan sulfate proteoglycan.

Conclusions:

• Cultured rat GEC synthesize and secrete a novel complement regulatory factor, GCRF.
• GCRF is a dermatan sulfate proteoglycan that inhibits complement activation by targeting alternative pathway C3/C5 convertases.
• GCRF represents a potential therapeutic target for modulating complement-mediated inflammatory conditions.